Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2025 Earnings Call Transcript
Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2025 Earnings Call Transcript November 5, 2025Revolution Medicines, Inc. misses on earnings expectations.
Revolution Medicines Inc. (RVMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 14,625,692 | $683,019,816 | +3% | 2.8% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 9,455,357 | $441,565,172 | +1% | 3.19% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,974,913 | $185,628,437 | -21% | 7.52% |
| 4. | Deerfield Management James E. Flynn | 3,650,342 | $170,470,971 | +8% | 2.6% |
| 5. | Holocene Advisors Brandon Haley | 3,437,283 | $160,521,116 | -6% | 0.37% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $46.00 | 760,869 | $34,999,974.00 | 760,869 | 2024-12-05 | Filing | |
| $46.00 | 543,478 | $24,999,988.00 | 2,096,612 | 2024-12-05 | Filing | |
| $20.85 | 6,200 | $129,270.00 | 1,553,134 | 2023-03-10 | Filing | |
| $20.43 | 93,800 | $1,916,334.00 | 1,546,934 | 2023-03-10 | Filing | |
| $22.00 | 318,181 | $6,999,982.00 | 618,181 | 2023-03-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $74.00 | 5,418 | $400,932.00 | 110,994 | 2025-11-25 | Filing | |
| $75.00 | 3,000 | $225,000.00 | 67,424 | 2025-11-25 | Filing | |
| $75.00 | 3,000 | $225,000.00 | 67,424 | 2025-11-25 | Filing | |
| $75.08 | 60,000 | $4,504,962.00 | 247,863 | 2025-11-25 | Filing | |
| $70.38 | 20,000 | $1,407,586.00 | 247,863 | 2025-11-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,663,094 | $731,466,490 | 0.01% | |
| 2. | 11,356,054 | $530,307,153 | 0.24% | |
| 3. | 9,813,436 | $458,287,462 | 0.08% | |
| 4. | 9,401,687 | $439,058,770 | 0.02% | |
| 5. | 8,327,758 | $388,906,300 | 0.01% |
News See All
Jim Cramer Recently Offered Insights on These 11 Stocks
Jim Cramer, the host of Mad Money, on Thursday addressed the sharp downturn in markets driven by mounting concerns over deteriorating bank loans.
Revolution Medicines, Inc. (RVMD) Insider Sells Shares
Revolution Medicines, Inc. (NASDAQ:RVMD) is among the most promising biotech stocks to buy according to hedge funds. On September 24, 2025, General Counsel and Officer of Revolution Medicines, Inc.
7 Most Promising Biotech Stocks to Buy According to Hedge Funds
If there’s one sector that is gaining popularity each day, it’s definitely the biotechnology market.
Oppenheimer Reaffirms Outperform on Revolution Medicines (RVMD) Amid RAS Therapy Progress
Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the best mid-cap stocks with huge upside potential.
12 Best Mid-Cap Stocks with Huge Upside Potential
The Commerce Department said on August 29 that core inflation, which does not include food and energy expenses, stood at a 2.9% seasonally adjusted annual rate based on the personal consumption expenditures...
13 Best Mid Cap Growth Stocks to Buy According to Hedge Funds
On August 26, Courtney Garcia, Payne Capital Management senior wealth advisor, joined CNBC television for an interview to discuss whether investors should continue buying in the current market scenario...
Piper Sandler Initiates Coverage of Revolution Medicines (RVMD) with an Overweight Rating
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the most promising future stocks according to Wall Street analysts. On August 18, Piper Sandler initiated coverage of Revolution Medicines, Inc.
12 Most Promising Future Stocks According to Wall Street Analysts
Stockton further stated that while breadth hasn’t been great, it hasn’t been terrible either, not being wholly related to the mega caps.
Revolution Medicines Receives FDA Breakthrough Therapy Designation for Elironrasib for Lung Cancer
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best upside stocks to invest in now.